State Seeks Input from Utah Insulin Users to Support Ongoing Lawsuit

The Utah Department of Commerce’s Division of Consumer Protection is encouraging Utah residents to share their experiences with insulin pricing.

SALT LAKE CITY—The Utah Division of Consumer Protection (Consumer Protection) is inviting current and former Utah diabetes patients and their caregivers to share their experiences with insulin pricing over the past ten years. The feedback will support the state’s legal action against major insulin manufacturers and pharmacy benefit managers (PBMs) for pricing schemes that have unjustly increased the cost of life-saving medication.
 
“These companies have preyed on individuals by artificially inflating the prices of life-saving drugs, forcing families to choose between their medication and basic necessities like food,” stated Dan Larsen, Director of the Utah Division of Consumer Protection. “Your experience is vital to the state’s case and our potential to recover damages as we work to ensure these companies are held to account.”
 
Individuals who have suffered harm may ultimately be eligible to receive compensation. Participation takes only a few minutes. Fill out the official submission form at commerce.utah.gov/dcp/insulin.
 

Legal Claims and Industry Practices

The state’s lawsuit addresses several practices that have driven insulin costs to unsustainable levels:

• Artificially Inflated Prices: Drug manufacturers allegedly raised wholesale insulin prices to provide higher rebates to PBMs
   
• Middleman Rebate Schemes: PBMs allegedly prioritized high-rebate, high-cost drugs over more affordable options on health plan formularies
   
• Patient Financial Strain: Utah residents have faced higher out-of-pocket costs due to artificial list prices rather than actual market costs
   

Approximately 200,000 Utahns live with diabetes, spending $1.7 billion on care, which accounts for one in four healthcare dollars spent in the state. Consumer Protection, represented by the Utah Attorney General’s Office, is leading litigation to reform the pharmaceutical supply chain and ensure fair, transparent pricing for Utah families.

Insulin user experiences are critical evidence in Utah’s fight to stop these predatory pricing practices, recover damages, and protect Utah families going forward.  Learn more about the lawsuit and how you can help at commerce.utah.gov/dcp/insulin.

*Submissions will be treated as official complaints and reviewed by investigators to support the lawsuit.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.